Organigram EU

Amsterdam, NetherlandsFounded 2020

Producer & Grower NASDAQ: OGI www.organigram.ca

Share:X / Twitter LinkedIn Suggest a correction

About Organigram EU

Organigram EU is the European arm of Organigram Holdings, a Canadian licensed producer known for innovation in cannabis products. The Netherlands-based office coordinates the company's European expansion strategy and partnerships in the growing EU medical cannabis sector.

Key Facts

1Parent company Organigram Holdings trades on NASDAQ under OGI
2Known in Canada for innovative products like fast-acting edibles and nanoemulsion technology
3Uses the Netherlands as a launchpad for European medical cannabis market entry
4British American Tobacco holds a significant investment stake in the parent company

Latest News

Organigram Holdings Near 52-Week Low as Cannabis Sector Struggles

3d ago

OGI trades at $0.87, just 2% above its 52-week low of $0.85, reflecting broader cannabis industry challenges and company-specific pressures.

OGI Stock Tests Canadian Cannabis Profit Viability Amid Sector Shakeout

8d ago

Organigram Holdings faces critical profitability challenges as Canada's cannabis market consolidates around sustainable operators.

Organigram Outlines Strategic Vision as Cannabis Volatility Persists

13d ago

OGI management details operational priorities and market positioning strategy while cannabis sector faces continued price pressure and uncertainty.

View all OGI news

Frequently Asked Questions

What is Organigram known for?

Organigram is known for product innovation in the Canadian cannabis market, including fast-dissolving cannabis products, nanoemulsion technology, and consistent quality cultivation. They are exploring bringing these innovations to European markets.

Does Organigram sell products in European pharmacies?

Organigram's European presence is focused on market development and partnerships. Direct product availability depends on specific country regulations and distribution agreements.